Dutcher JP - Search Results

1

Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma.

Sparano JA, Fisher RI, Sunderland M, Margolin K, Ernest ML, Sznol M, Atkins MB, Dutcher JP, Micetich KC, Weiss GR, et al. Sparano JA, et al. Among authors: dutcher jp. J Clin Oncol. 1993 Oct;11(10):1969-77. doi: 10.1200/JCO.1993.11.10.1969. J Clin Oncol. 1993. PMID: 8410122 Clinical Trial.

2

A phase II study of taxol in patients with malignant melanoma.

Einzig AI, Hochster H, Wiernik PH, Trump DL, Dutcher JP, Garowski E, Sasloff J, Smith TJ. Einzig AI, et al. Among authors: dutcher jp. Invest New Drugs. 1991 Feb;9(1):59-64. doi: 10.1007/BF00194546. Invest New Drugs. 1991. PMID: 1673965 Clinical Trial.

3

A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma.

Weiss GR, Margolin KA, Aronson FR, Sznol M, Atkins MB, Dutcher JP, Gaynor ER, Boldt DH, Doroshow JH, Bar MH, et al. Weiss GR, et al. Among authors: dutcher jp. J Clin Oncol. 1992 Feb;10(2):275-81. doi: 10.1200/JCO.1992.10.2.275. J Clin Oncol. 1992. PMID: 1732429 Clinical Trial.

4

Colonic ischemia complicating immunotherapy with interleukin-2 and interferon-alpha.

Sparano JA, Dutcher JP, Kaleya R, Caliendo G, Fiorito J, Mitsudo S, Shechner R, Boley SJ, Gucalp R, Ciobanu N, et al. Sparano JA, et al. Among authors: dutcher jp. Cancer. 1991 Oct 1;68(7):1538-44. doi: 10.1002/1097-0142(19911001)68:7<1538::aid-cncr2820680714>3.0.co;2-2. Cancer. 1991. PMID: 1893354

5

A phase II study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanoma.

Dutcher JP, Gaynor ER, Boldt DH, Doroshow JH, Bar MH, Sznol M, Mier J, Sparano J, Fisher RI, Weiss G, et al. Dutcher JP, et al. J Clin Oncol. 1991 Apr;9(4):641-8. doi: 10.1200/JCO.1991.9.4.641. J Clin Oncol. 1991. PMID: 2066760 Clinical Trial.

6

A phase I study of high-dose interleukin-2 in combination with interferon-alpha 2b.

Sznol M, Mier JW, Sparano J, Gaynor ER, Weiss GR, Margolin KA, Bar MH, Hawkins MJ, Atkins MB, Dutcher JP, et al. Sznol M, et al. Among authors: dutcher jp. J Biol Response Mod. 1990 Dec;9(6):529-37. J Biol Response Mod. 1990. PMID: 2074439 Clinical Trial.

7

Successful treatment of hairy cell leukemia with beta-ser interferon.

Wiernik PH, Schwartz B, Dutcher JP, Turman N, Adinolfi C. Wiernik PH, et al. Among authors: dutcher jp. Am J Hematol. 1990 Apr;33(4):244-8. doi: 10.1002/ajh.2830330406. Am J Hematol. 1990. PMID: 2082943

8

Successful treatment of hair cell leukemia with 2'-deoxycoformycin after failure of interferons alpha or beta.

Dutcher JP, Salva KM, Wiernik PH. Dutcher JP, et al. Am J Clin Oncol. 1990 Aug;13(4):290-3. doi: 10.1097/00000421-199008000-00004. Am J Clin Oncol. 1990. PMID: 2198792 Review.

9

Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study.

Parkinson DR, Abrams JS, Wiernik PH, Rayner AA, Margolin KA, Van Echo DA, Sznol M, Dutcher JP, Aronson FR, Doroshow JH, et al. Parkinson DR, et al. Among authors: dutcher jp. J Clin Oncol. 1990 Oct;8(10):1650-6. doi: 10.1200/JCO.1990.8.10.1650. J Clin Oncol. 1990. PMID: 2213101 Clinical Trial.

10

Acute renal dysfunction during interleukin-2 treatment: suggestion of an intrinsic renal lesion.

Shalmi CL, Dutcher JP, Feinfeld DA, Chun KJ, Saleemi KR, Freeman LM, Lynn RI, Wiernik PH. Shalmi CL, et al. Among authors: dutcher jp. J Clin Oncol. 1990 Nov;8(11):1839-46. doi: 10.1200/JCO.1990.8.11.1839. J Clin Oncol. 1990. PMID: 2230870

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

295 results

Search Page

Filters